Emulsifying Ointment

País: Irlanda

Idioma: anglès

Font: HPRA (Health Products Regulatory Authority)

Compra'l ara

Descargar Fitxa tècnica (SPC)
11-12-2017

ingredients actius:

Liquid paraffin; White soft paraffin; Emulsifying wax

Disponible des:

Ovelle Limited

Codi ATC:

D02AX

Designació comuna internacional (DCI):

Liquid paraffin; White soft paraffin; Emulsifying wax

Dosis:

30%w/w + 50%w/w + 20 percent weight/weight

formulario farmacéutico:

Ointment

tipo de receta:

Product not subject to medical prescription

Área terapéutica:

Other emollients and protectives

Estat d'Autorització:

Marketed

Data d'autorització:

1988-11-18

Fitxa tècnica

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Emulsifying Ointment
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Emulsifying wax
30% w/w
[Cetostearyl Alcohol
Sodium Lauryl Sulphate
Purified Water]
White soft paraffin
50% w/w
Liquid paraffin
20% w/w
3 PHARMACEUTICAL FORM
Ointment.
White semi-opaque ointment with characteristic odour and smooth
texture.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
a)
Moisturiser and emollient that soothes and helps to hydrate dry skin.
b)
Soap substitute.
Eczema and other dry skin conditions.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Apply as often as required to prevent itching and flaking dry skin.
Soap substitute. See patients information sheet.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
For external use only.
Cetostearyl alcohol may cause local skin reactions (e.g. contact
dermatitis).
Sodium laurilsulfate (E 487) may cause local skin reactions (such as
stinging or burning sensation) or increase skin
reactions caused by other products when applied on the same
area.Sensitivity to SLS can vary according to body site,
age and patient population (children, hydration level, skin color and
disease). Patient populations with decreased skin
barrier functions such as in atopic dermatitis are more sensitive to
the irritant properties of SLS.
Adults:
as above
Babies:
as above
Elderly:
as above
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_7_
_/_
_1_
_1_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_2_
_1_

                                
                                Llegiu el document complet
                                
                            

Cerqueu alertes relacionades amb aquest producte

Veure l'historial de documents